Recent Updates
Recently added Catalysts
SDGR Positive Sentiment

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Tuesday, September 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Schrödinger, Inc. announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference. The management will engage in a fireside chat on September 14, 2026, at 1:05 p.m. E.T. The presentation will be available via live webcast and archived for 90 days. Schrödinger's platform is recognized for its role in drug development.
Price reaction · baseline $19.5 (2026-08-31 close) · hit pre-market · clean, no other SDGR news in the window
day 0 close
+6.9%
day 1 · peak
+7.1%
day 3
+3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Schrödinger is participating in a prominent healthcare conference.
  • The event provides an opportunity for investor engagement.
  • The company's innovative computational platform is highlighted.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+15%
120-day peak, hindsight
Typical move
0.5%
average across 2 past catalysts
Cash runway
~34 mo
Minimal dilution risk

Full Press Release Details

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The live presentation will take place on Monday, September 14, 2026 at 1:05 p.m. E.T.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.
About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs. To learn more, visit www.schrodinger.com , follow us on LinkedIn , or visit our blog, Extrapolations.com .
Matthew Luchini Schrödinger, Inc. matthew.luchini@schrodinger.com 917-719-0636
Multimedia Files:

Frequently Asked Questions

When will Schrödinger present at the conference?

Schrödinger will present on September 14, 2026, at 1:05 p.m. E.T.

How can I access the presentation?

The presentation will be available via live webcast on Schrödinger's website.

What is Schrödinger known for?

Schrödinger is known for its computational platform for drug development and materials design.

How long will the webcast be available?

The webcast will be archived for approximately 90 days after the event.

ShareAdd on Google
Tags: SDGR Schrödinger Morgan Stanley healthcare conference investor presentation
Last updated: Sep 1, 2026

Biotech snapshot

Cash runway
$414M liquidity · $11M/mo burn
~34 mo
Minimal dilution risk

Catalyst track record

+15%
best trade around SDGR's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for SDGR.

See every catalyst's timing & PoA →